Press release
Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSNL)
An investigation for investors in Personalis, Inc. (NASDAQ: PSNL) shares over potential securities laws violations by Personalis,
Investors who purchased shares of Personalis, Inc. (NASDAQ: PSNL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Personalis, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Menlo Park, CA based Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. conducted an initial public offering ("IPO") in June 2019. Shares of Personalis, Inc. (NASDAQ: PSNL) were offered at $17.00 per share in the IPO and reached a high of $31.88 immediately following the IPO. Shares of Personalis, Inc. (NASDAQ: PSNL) declined to as low as $2.7 per share on March 17, 2020.
On April 17, 2020, shares of Personalis, Inc. (NASDAQ: PSNL) closed at $8.81 per share.
Those who purchased shares of Personalis, Inc. (NASDAQ: PSNL) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSNL) here
News-ID: 2019406 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Personalis
PERSONALIZED CANCER VACCINES MARKET SIZE & SHARE ANALYSIS BY NEON THERAPEUTICS, …
The Personalized Cancer Vaccines Market report explains the growing popularity of the market competition by leading manufacturers or players, with sales volume, revenue (Million USD), price (USD/Unit), and market share for every individual manufacturer or player. Furthermore, the scope of this Personalized Cancer Vaccines Market report includes in-depth insights of global and regional markets with the sense given for variation in the growth of the Pharmaceutical industry in certain regions.…
Global Precision Medicine Market Next Big Thing | Major Giants Neon Therapeutic …
Data Bridge Market Research has recently added a concise research on the Global Precision Medicine Market to depict valuable insights related to significant market trends driving the industry. Global Precision Medicine Market report comprises of crucial aspects of the market that contains industry research, market sizing & forecast, competitive intelligence, market entry strategy, pricing trends, sustainability trends, customer insights, technology evolution, innovation trends, and distribution channel assessment. With this report, businesses…
Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSN …
An investigation was announced concerning potential securities laws violations by Personalis, Inc. in connection with certain financial statements.
Investors who purchased shares of Personalis, Inc. (NASDAQ: PSNL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Personalis, Inc. regarding its business, its prospects and its operations were materially false and…
Gene Panel Market By Top Leading Players : Eurofins Scientific, F. Hoffmann-La R …
Worldwide Gene Panel Market Analysis to 2025 is a specialized and in-depth study of the Gene Panel industry with a focus on the global market trend. The report aims to provide an overview of global Gene Panel Market with detailed market segmentation by product/application and geography. The global Gene Panel Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status…
Gene Panel Market Global Outlook to 2025 - Personalis Inc., ArcherDX, Inc., QIAG …
Worldwide Gene Panel Market Analysis to 2025 is a specialized and in-depth study of the Gene Panel industry with a focus on the global market trend. The report aims to provide an overview of global Gene Panel Market with detailed market segmentation by product/application and geography. The global Gene Panel Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status…
Major Advancements of Global Next-Generation Sequencing (NGS) Services Market 20 …
Researchmoz added Most up-to-date research on "Global Next-Generation Sequencing (NGS) Services Sales Market Report 2018" to its huge collection of research reports.
This report studies the global Next-Generation Sequencing (NGS) Services market status and forecast, categorizes the global Next-Generation Sequencing (NGS) Services market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and…
